ProPhase Labs, Inc. (PRPH)
0.138
+0.01
(+6.15%)
USD |
NASDAQ |
Dec 08, 16:00
0.1303
-0.01
(-5.58%)
Pre-Market: 09:22
ProPhase Labs Total Liabilities (Quarterly): 58.84M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| FONAR Corp. | 56.96M |
| XWELL, Inc. | 18.68M |
| Veracyte, Inc. | 110.12M |
| Insight Molecular Diagnostics, Inc. | 53.13M |
| Exagen, Inc. | 44.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.70M |
| Shareholders Equity (Quarterly) | 6.861M |
| Debt to Equity Ratio | 1.12 |
| Current Ratio | 0.1406 |
| Net Debt Paydown Yield | 16.46% |